State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Oral Cavity & Pharynx (Late Stage^), 2015-2019

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Count

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

US (SEER+NPCR)¹

• Rate : The incidence rate is 7.4 with a 95% confidence interval from 7.4 to 7.5 and 29,392 average annual cases over 2015-2019.
• CI*Rank⋔ : N/A
• Percent of Cases with Late Stage : 62.7

California³

• Rate : The incidence rate is 6.5 with a 95% confidence interval from 6.4 to 6.6 and 2,888 average annual cases over 2015-2019.
• CI*Rank⋔ : 46 (40, 47)
• Percent of Cases with Late Stage : 63.9

Florida⁶

• Rate : The incidence rate is 8.4 with a 95% confidence interval from 8.3 to 8.6 and 2,459 average annual cases over 2015-2019.
• CI*Rank⋔ : 7 (4, 14)
• Percent of Cases with Late Stage : 60.6

Texas³

• Rate : The incidence rate is 6.6 with a 95% confidence interval from 6.5 to 6.7 and 1,968 average annual cases over 2015-2019.
• CI*Rank⋔ : 42 (37, 46)
• Percent of Cases with Late Stage : 59.5

New York³

• Rate : The incidence rate is 7.2 with a 95% confidence interval from 7.0 to 7.4 and 1,759 average annual cases over 2015-2019.
• CI*Rank⋔ : 33 (26, 38)
• Percent of Cases with Late Stage : 63.5

Pennsylvania⁶

• Rate : The incidence rate is 7.9 with a 95% confidence interval from 7.7 to 8.1 and 1,345 average annual cases over 2015-2019.
• CI*Rank⋔ : 18 (12, 26)
• Percent of Cases with Late Stage : 64.2

Ohio⁶

• Rate : The incidence rate is 8.2 with a 95% confidence interval from 8.0 to 8.4 and 1,228 average annual cases over 2015-2019.
• CI*Rank⋔ : 14 (6, 20)
• Percent of Cases with Late Stage : 66.4

Illinois³

• Rate : The incidence rate is 7.8 with a 95% confidence interval from 7.6 to 8.0 and 1,209 average annual cases over 2015-2019.
• CI*Rank⋔ : 21 (14, 28)
• Percent of Cases with Late Stage : 64.6

North Carolina⁶

• Rate : The incidence rate is 8.3 with a 95% confidence interval from 8.0 to 8.5 and 1,056 average annual cases over 2015-2019.
• CI*Rank⋔ : 12 (5, 20)
• Percent of Cases with Late Stage : 66.0

Georgia³

• Rate : The incidence rate is 8.6 with a 95% confidence interval from 8.4 to 8.9 and 1,029 average annual cases over 2015-2019.
• CI*Rank⋔ : 5 (2, 12)
• Percent of Cases with Late Stage : 68.2

Michigan⁶

• Rate : The incidence rate is 7.6 with a 95% confidence interval from 7.4 to 7.9 and 985 average annual cases over 2015-2019.
• CI*Rank⋔ : 24 (17, 31)
• Percent of Cases with Late Stage : 64.4

New Jersey³

• Rate : The incidence rate is 7.1 with a 95% confidence interval from 6.9 to 7.3 and 807 average annual cases over 2015-2019.
• CI*Rank⋔ : 34 (27, 41)
• Percent of Cases with Late Stage : 63.0

Virginia⁶

• Rate : The incidence rate is 6.8 with a 95% confidence interval from 6.6 to 7.1 and 710 average annual cases over 2015-2019.
• CI*Rank⋔ : 38 (31, 45)
• Percent of Cases with Late Stage : 61.8

Tennessee⁶

• Rate : The incidence rate is 8.4 with a 95% confidence interval from 8.1 to 8.7 and 708 average annual cases over 2015-2019.
• CI*Rank⋔ : 9 (3, 19)
• Percent of Cases with Late Stage : 64.7

Massachusetts³

• Rate : The incidence rate is 7.8 with a 95% confidence interval from 7.5 to 8.1 and 684 average annual cases over 2015-2019.
• CI*Rank⋔ : 20 (12, 29)
• Percent of Cases with Late Stage : 67.0

Indiana⁶

• Rate : The incidence rate is 8.1 with a 95% confidence interval from 7.8 to 8.4 and 652 average annual cases over 2015-2019.
• CI*Rank⋔ : 15 (6, 25)
• Percent of Cases with Late Stage : 64.1

Missouri⁶

• Rate : The incidence rate is 8.4 with a 95% confidence interval from 8.1 to 8.7 and 651 average annual cases over 2015-2019.
• CI*Rank⋔ : 8 (3, 18)
• Percent of Cases with Late Stage : 66.7

Washington⁵

• Rate : The incidence rate is 7.2 with a 95% confidence interval from 7.0 to 7.5 and 647 average annual cases over 2015-2019.
• CI*Rank⋔ : 32 (23, 39)
• Percent of Cases with Late Stage : 59.0

Wisconsin⁶

• Rate : The incidence rate is 7.9 with a 95% confidence interval from 7.6 to 8.2 and 595 average annual cases over 2015-2019.
• CI*Rank⋔ : 19 (10, 30)
• Percent of Cases with Late Stage : 63.7

South Carolina⁶

• Rate : The incidence rate is 8.0 with a 95% confidence interval from 7.7 to 8.3 and 526 average annual cases over 2015-2019.
• CI*Rank⋔ : 17 (7, 27)
• Percent of Cases with Late Stage : 65.2

Maryland⁶

• Rate : The incidence rate is 7.0 with a 95% confidence interval from 6.7 to 7.2 and 521 average annual cases over 2015-2019.
• CI*Rank⋔ : 36 (27, 44)
• Percent of Cases with Late Stage : 62.8

Kentucky³

• Rate : The incidence rate is 9.2 with a 95% confidence interval from 8.8 to 9.5 and 513 average annual cases over 2015-2019.
• CI*Rank⋔ : 2 (1, 6)
• Percent of Cases with Late Stage : 66.9

Arizona⁶

• Rate : The incidence rate is 5.3 with a 95% confidence interval from 5.1 to 5.5 and 469 average annual cases over 2015-2019.
• CI*Rank⋔ : 50 (47, 50)
• Percent of Cases with Late Stage : 58.8

Louisiana³

• Rate : The incidence rate is 8.3 with a 95% confidence interval from 8.0 to 8.7 and 467 average annual cases over 2015-2019.
• CI*Rank⋔ : 11 (3, 21)
• Percent of Cases with Late Stage : 64.7

Minnesota⁶

• Rate : The incidence rate is 6.6 with a 95% confidence interval from 6.3 to 6.9 and 453 average annual cases over 2015-2019.
• CI*Rank⋔ : 44 (35, 47)
• Percent of Cases with Late Stage : 54.2

Oregon⁶

• Rate : The incidence rate is 8.0 with a 95% confidence interval from 7.7 to 8.4 and 427 average annual cases over 2015-2019.
• CI*Rank⋔ : 16 (6, 28)
• Percent of Cases with Late Stage : 65.5

Colorado⁶

• Rate : The incidence rate is 6.5 with a 95% confidence interval from 6.3 to 6.8 and 425 average annual cases over 2015-2019.
• CI*Rank⋔ : 45 (35, 47)
• Percent of Cases with Late Stage : 61.2

Alabama⁶

• Rate : The incidence rate is 6.8 with a 95% confidence interval from 6.5 to 7.1 and 421 average annual cases over 2015-2019.
• CI*Rank⋔ : 40 (30, 46)
• Percent of Cases with Late Stage : 53.6

Connecticut³

• Rate : The incidence rate is 7.6 with a 95% confidence interval from 7.2 to 7.9 and 361 average annual cases over 2015-2019.
• CI*Rank⋔ : 26 (15, 36)
• Percent of Cases with Late Stage : 61.3

Oklahoma⁶

• Rate : The incidence rate is 7.4 with a 95% confidence interval from 7.1 to 7.8 and 345 average annual cases over 2015-2019.
• CI*Rank⋔ : 27 (17, 38)
• Percent of Cases with Late Stage : 57.2

Arkansas⁶

• Rate : The incidence rate is 8.9 with a 95% confidence interval from 8.5 to 9.3 and 330 average annual cases over 2015-2019.
• CI*Rank⋔ : 3 (1, 13)
• Percent of Cases with Late Stage : 62.8

Iowa³

• Rate : The incidence rate is 8.3 with a 95% confidence interval from 7.9 to 8.8 and 328 average annual cases over 2015-2019.
• CI*Rank⋔ : 10 (3, 24)
• Percent of Cases with Late Stage : 58.5

Mississippi⁶

• Rate : The incidence rate is 8.2 with a 95% confidence interval from 7.8 to 8.6 and 301 average annual cases over 2015-2019.
• CI*Rank⋔ : 13 (3, 25)
• Percent of Cases with Late Stage : 64.4

Kansas⁶

• Rate : The incidence rate is 7.1 with a 95% confidence interval from 6.7 to 7.5 and 247 average annual cases over 2015-2019.
• CI*Rank⋔ : 35 (23, 45)
• Percent of Cases with Late Stage : 60.2

West Virginia⁶

• Rate : The incidence rate is 9.6 with a 95% confidence interval from 9.0 to 10.1 and 240 average annual cases over 2015-2019.
• CI*Rank⋔ : 1 (1, 5)
• Percent of Cases with Late Stage : 68.8

Puerto Rico⁶

• Rate : The incidence rate is 4.6 with a 95% confidence interval from 4.3 to 4.9 and 186 average annual cases over 2015-2019.
• CI*Rank⋔ : N/A
• Percent of Cases with Late Stage : 47.6

Maine⁶

• Rate : The incidence rate is 8.9 with a 95% confidence interval from 8.3 to 9.5 and 173 average annual cases over 2015-2019.
• CI*Rank⋔ : 4 (1, 18)
• Percent of Cases with Late Stage : 63.9

Nebraska⁶

• Rate : The incidence rate is 7.3 with a 95% confidence interval from 6.8 to 7.9 and 166 average annual cases over 2015-2019.
• CI*Rank⋔ : 29 (14, 44)
• Percent of Cases with Late Stage : 58.0

Utah³

• Rate : The incidence rate is 5.8 with a 95% confidence interval from 5.4 to 6.2 and 162 average annual cases over 2015-2019.
• CI*Rank⋔ : 48 (45, 50)
• Percent of Cases with Late Stage : 58.3

New Mexico³

• Rate : The incidence rate is 5.5 with a 95% confidence interval from 5.1 to 5.9 and 144 average annual cases over 2015-2019.
• CI*Rank⋔ : 49 (46, 50)
• Percent of Cases with Late Stage : 61.7

Idaho³

• Rate : The incidence rate is 6.9 with a 95% confidence interval from 6.4 to 7.4 and 143 average annual cases over 2015-2019.
• CI*Rank⋔ : 37 (22, 47)
• Percent of Cases with Late Stage : 56.7

New Hampshire⁶

• Rate : The incidence rate is 7.3 with a 95% confidence interval from 6.8 to 7.9 and 139 average annual cases over 2015-2019.
• CI*Rank⋔ : 30 (13, 45)
• Percent of Cases with Late Stage : 62.1

Hawaii³

• Rate : The incidence rate is 7.6 with a 95% confidence interval from 7.0 to 8.2 and 136 average annual cases over 2015-2019.
• CI*Rank⋔ : 25 (6, 40)
• Percent of Cases with Late Stage : 58.9

Rhode Island⁶

• Rate : The incidence rate is 7.7 with a 95% confidence interval from 7.1 to 8.4 and 109 average annual cases over 2015-2019.
• CI*Rank⋔ : 22 (4, 40)
• Percent of Cases with Late Stage : 66.3

Montana⁶

• Rate : The incidence rate is 7.3 with a 95% confidence interval from 6.6 to 8.0 and 103 average annual cases over 2015-2019.
• CI*Rank⋔ : 31 (10, 46)
• Percent of Cases with Late Stage : 61.6

Delaware⁶

• Rate : The incidence rate is 7.7 with a 95% confidence interval from 7.0 to 8.4 and 100 average annual cases over 2015-2019.
• CI*Rank⋔ : 23 (4, 42)
• Percent of Cases with Late Stage : 62.6

Vermont⁶

• Rate : The incidence rate is 8.5 with a 95% confidence interval from 7.6 to 9.4 and 73 average annual cases over 2015-2019.
• CI*Rank⋔ : 6 (1, 34)
• Percent of Cases with Late Stage : 68.5

South Dakota⁶

• Rate : The incidence rate is 6.6 with a 95% confidence interval from 5.9 to 7.4 and 70 average annual cases over 2015-2019.
• CI*Rank⋔ : 43 (24, 49)
• Percent of Cases with Late Stage : 56.8

North Dakota⁶

• Rate : The incidence rate is 6.8 with a 95% confidence interval from 6.0 to 7.6 and 59 average annual cases over 2015-2019.
• CI*Rank⋔ : 39 (16, 48)
• Percent of Cases with Late Stage : 56.5

Alaska⁶

• Rate : The incidence rate is 7.4 with a 95% confidence interval from 6.5 to 8.3 and 59 average annual cases over 2015-2019.
• CI*Rank⋔ : 28 (4, 47)
• Percent of Cases with Late Stage : 65.7

District of Columbia⁶

• Rate : The incidence rate is 6.7 with a 95% confidence interval from 5.9 to 7.6 and 47 average annual cases over 2015-2019.
• CI*Rank⋔ : 41 (14, 49)
• Percent of Cases with Late Stage : 62.6

Wyoming⁶

• Rate : The incidence rate is 5.9 with a 95% confidence interval from 5.1 to 6.8 and 42 average annual cases over 2015-2019.
• CI*Rank⋔ : 47 (33, 50)
• Percent of Cases with Late Stage : 56.3

Nevada⁶

• Rate : Data not available for this combination of data selections.
• CI*Rank⋔ : N/A
• Percent of Cases with Late Stage : data not available

Notes:
Created by statecancerprofiles.cancer.gov on 05/29/2023 8:35 am.

State Cancer Registries may provide more current or more local data.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

¹ Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2019) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2021 submission.
³ Source: SEER November 2021 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
⁵ Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2019) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2021 submission.
⁶ Source: National Program of Cancer Registries SEER*Stat Database (2001-2019) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2021 submission).

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.